A new study claims AI drug companies are recklessly patenting untested molecules, but the analysis reveals a fundamental misunderstanding of how pharmaceutical patents actually work. The study entitled "What patents on AI-derived drugs reveal" (Freilich & Rai) was recently published in the journal Science. The authors analysed granted drug compound patents from over 100 AI-drug